These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23466836)

  • 21. Neural Basis of Apathy in Patients with Amnestic Mild Cognitive Impairment.
    Kazui H; Takahashi R; Yamamoto Y; Yoshiyama K; Kanemoto H; Suzuki Y; Sato S; Azuma S; Suehiro T; Shimosegawa E; Ishii K; Tanaka T
    J Alzheimers Dis; 2017; 55(4):1403-1416. PubMed ID: 27858707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR imaging texture analysis of the corpus callosum and thalamus in amnestic mild cognitive impairment and mild Alzheimer disease.
    de Oliveira MS; Balthazar ML; D'Abreu A; Yasuda CL; Damasceno BP; Cendes F; Castellano G
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):60-6. PubMed ID: 20966061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease.
    Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Rhee SJ; Lee SY; Wang Y; Jahng GH
    Neuroimage Clin; 2017; 16():429-438. PubMed ID: 28879084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer's disease.
    Agostini S; Mancuso R; Baglio F; Cabinio M; Hernis A; Costa AS; Calabrese E; Nemni R; Clerici M
    Brain Behav Immun; 2016 Nov; 58():254-260. PubMed ID: 27470229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prediction of conversion from amnestic mild cognitive impairment to Alzheimer's disease using proton magnetic resonance spectroscopy].
    Watanabe T; Shiino A; Akiguchi I
    Rinsho Shinkeigaku; 2015; 55(10):709-15. PubMed ID: 26369373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of diffusion tensor imaging for evaluating changes in the microstructural integrity of white matter over 3 years in patients with amnesic-type mild cognitive impairment converting to Alzheimer's disease.
    Fu JL; Liu Y; Li YM; Chang C; Li WB
    J Neuroimaging; 2014; 24(4):343-8. PubMed ID: 24251793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of cortical thickness in patients with early-stage versus late-stage amnestic mild cognitive impairment.
    Ye BS; Seo SW; Yang JJ; Kim HJ; Kim YJ; Yoon CW; Cho H; Noh Y; Kim GH; Chin J; Kim JH; Jeon S; Lee JM; Na DL
    Eur J Neurol; 2014; 21(1):86-92. PubMed ID: 24033766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Textural features reflecting local activity of the hippocampus improve the diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: A radiomics study based on functional magnetic resonance imaging.
    Wang L; Feng Q; Ge X; Chen F; Yu B; Chen B; Liao Z; Lin B; Lv Y; Ding Z
    Front Neurosci; 2022; 16():970245. PubMed ID: 36003964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
    Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-space path integration is impaired in Alzheimer's disease and mild cognitive impairment.
    Mokrisova I; Laczo J; Andel R; Gazova I; Vyhnalek M; Nedelska Z; Levcik D; Cerman J; Vlcek K; Hort J
    Behav Brain Res; 2016 Jul; 307():150-8. PubMed ID: 27038766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcortical and Cerebellar Neural Correlates of Prodromal Alzheimer's Disease with Prolonged Sleep Latency.
    Um YH; Wang SM; Kang DW; Kim NY; Lim HK
    J Alzheimers Dis; 2022; 86(2):565-578. PubMed ID: 35068468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
    Moon Y; Han SH; Moon WJ
    J Alzheimers Dis; 2016; 51(3):737-45. PubMed ID: 26890777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal intrinsic brain activity in amnestic mild cognitive impairment revealed by amplitude of low-frequency fluctuation: a resting-state functional magnetic resonance imaging study.
    Xi Q; Zhao XH; Wang PJ; Guo QH; He Y
    Chin Med J (Engl); 2013; 126(15):2912-7. PubMed ID: 23924467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study.
    Yang Q; Zhou L; Liu C; Liu D; Zhang Y; Li C; Shang Y; Wei X; Li C; Wang J
    Brain Imaging Behav; 2018 Oct; 12(5):1479-1487. PubMed ID: 29297155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inter-hemispheric functional dysconnectivity mediates the association of corpus callosum degeneration with memory impairment in AD and amnestic MCI.
    Qiu Y; Liu S; Hilal S; Loke YM; Ikram MK; Xu X; Yeow Tan B; Venketasubramanian N; Chen CL; Zhou J
    Sci Rep; 2016 Sep; 6():32573. PubMed ID: 27581062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trail making test B and brain perfusion imaging in mild cognitive impairment and mild Alzheimer's disease.
    Terada S; Sato S; Nagao S; Ikeda C; Shindo A; Hayashi S; Oshima E; Yokota O; Uchitomi Y
    Psychiatry Res; 2013 Sep; 213(3):249-55. PubMed ID: 23830931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.